Neuropeptide effects on brain development to be expected from behavioral teratology

Area of Science:

• Neuroscience
• Developmental Biology
• Pharmacology

Background:

• Perinatal exposure to psychotropic drugs can cause lasting functional consequences in brain development, termed behavioral teratology or functional neuroteratology.
• The mechanism is believed to involve altered neurotransmitter levels during neurogenesis, leading to impaired neuronal circuitry.
• Neuropeptides, also present during early brain development, are candidates for neurotransmission and may influence nervous system organization.

Purpose of the Study:

• To summarize the current understanding of neuropeptides' role in functional neuroteratology.
• To explore the potential trophic and neuroteratological effects of neuropeptides following perinatal exposure.
• To highlight the need for further research given the increasing clinical use of neuropeptides.

Main Methods:

• Review of existing literature on perinatal drug exposure and brain development.
• Analysis of studies investigating neuropeptide levels and function during neurodevelopment.
• Synthesis of evidence regarding neuropeptide-induced neuroteratological effects.

Main Results:

• Some neuropeptides exhibit a trophic role in nervous system development.
• Perinatal manipulation involving certain neuropeptides can lead to neuroteratological outcomes.
• Evidence suggests anomalies in neuropeptide levels can contribute to functional neuroteratology.

Conclusions:

• Neuropeptides are implicated in both normal nervous system development and potential adverse effects from perinatal exposure.
• Further detailed studies are crucial to understand these effects, especially with rising clinical applications of neuropeptides.
• Understanding these impacts is vital for assessing risks associated with neuropeptide-based therapies.